| Literature DB >> 17615075 |
Shankar R Chowdhury1, Dale E King, Benjamin P Willing, Mark R Band, Jonathan E Beever, Adrienne B Lane, Juan J Loor, Juan C Marini, Laurie A Rund, Lawrence B Schook, Andrew G Van Kessel, H Rex Gaskins.
Abstract
BACKGROUND: To gain insight into host-microbe interactions in a piglet model, a functional genomics approach was used to address the working hypothesis that transcriptionally regulated genes associated with promoting epithelial barrier function are activated as a defensive response to the intestinal microbiota. Cesarean-derived germfree (GF) newborn piglets were colonized with adult swine feces, and villus and crypt epithelial cell transcriptomes from colonized and GF neonatal piglets were compared using laser-capture microdissection and high-density porcine oligonucleotide microarray technology.Entities:
Mesh:
Year: 2007 PMID: 17615075 PMCID: PMC1949829 DOI: 10.1186/1471-2164-8-215
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Intestinal epithelial gene expression modulated by microbiota in CONV versus GF piglets
| Functional class | Unigene ID | Gene description | FDR adjusted | Fold change1 |
| Transcription | Hs.444468 | CTD (carboxy-terminal domain) small phosphatase 1 ( | 0.007 | 1.57 |
| Hs.433879 | DNA directed RNA polymerase II polypeptide J-related gene ( | 0.001 | 1.33 | |
| Hs.509226 | FK506 binding protein 3, 25 kDa ( | 0.029 | 0.67 | |
| Hs.765 | GATA binding protein 1 (globin transcription factor 1, | 0.006 | 0.70 | |
| Hs.247478 | HLA-B associated transcript 4 ( | 0.042 | 1.24 | |
| Hs.535030 | Hypothetical protein MGC13098 ( | 0.046 | 1.64 | |
| Hs.200716 | Methyl CpG binding protein 2 ( | 0.007 | 0.65 | |
| Hs.509545 | Pre-B-cell leukemia transcription factor 2 ( | 0.007 | 1.51 | |
| Hs.643558 | Retinoblastoma binding protein 4 ( | 0.003 | 1.47 | |
| Hs.388034 | Retinoid × receptor, beta ( | 0.003 | 1.41 | |
| Hs.470412 | RNA binding motif, single stranded interacting protein 1 ( | 0.018 | 1.39 | |
| Hs.433343 | Serine/arginine repetitive matrix 2 ( | 0.001 | 1.46 | |
| Hs.470943 | Signal transducer and activator of transcription 1 ( | 0.001 | 1.86 | |
| Hs.194756 | Sine oculis homeobox homolog 6 ( | 0.008 | 1.86 | |
| Hs.525091 | Testis-specific kinase 2 ( | 0.006 | 1.24 | |
| Hs.369762 | Thymidylate synthetase ( | 0.043 | 0.71 | |
| Hs.389734 | Transcription elongation factor A (SII)-like 8 ( | 0.007 | 0.62 | |
| Hs.386390 | Transcriptional adaptor 3 (NGG1 homolog, yeast)-like ( | 0.007 | 1.58 | |
| Hs.517296 | V-ets erythroblastosis virus E26 oncogene homolog 2 ( | 0.002 | 1.40 | |
| Hs.490504 | Zinc finger protein 398 ( | 0.017 | 1.39 | |
| Hs.438536 | Zinc finger protein 705A ( | 0.017 | 1.42 | |
| Hs.371794 | Zinc finger, NFX1-type containing 1 ( | 0.007 | 1.67 | |
| Signal transduction | Hs.371240 | A kinase (PRKA) anchor protein 12 ( | 0.003 | 1.77 |
| Hs.150423 | Cyclin-dependent kinase 9 (CDC2-related kinase) ( | 0.039 | 1.59 | |
| Hs.173135 | Dual-specificity tyrosine phosphorylation regulated kinase 2 ( | 0.042 | 0.62 | |
| Hs.515415 | Inositol 1,4,5-trisphosphate 3-kinase C ( | 0.033 | 1.37 | |
| Hs.529400 | Interferon (alpha, beta and omega) receptor 1 ( | 0.013 | 1.53 | |
| Hs.520414 | Interferon (gamma) receptor 1 ( | 0.030 | 1.52 | |
| Hs.433442 | Kinesin-associated protein 3 ( | 0.012 | 1.53 | |
| Hs.133421 | Leukemia inhibitory factor receptor ( | 0.003 | 2.31 | |
| Hs.485262 | Mitochondrial carrier homolog 1 ( | 0.034 | 1.62 | |
| Hs.419640 | Parkinson disease 7 ( | 0.030 | 0.75 | |
| Hs.509067 | Platelet-derived growth factor receptor, beta polypeptide ( | 0.038 | 1.24 | |
| Hs.2890 | Protein kinase C, gamma ( | 0.035 | 0.59 | |
| Hs.513683 | Protein serine kinase H1 ( | 0.041 | 1.35 | |
| Hs.458417 | Regulator of G-protein signalling 8 ( | 0.036 | 1.45 | |
| Hs.88012 | signaling threshold regulating transmembrane adaptor 1 ( | 0.038 | 1.47 | |
| Hs.470943 | Signal transducer and activator of transcription 1 ( | 0.001 | 1.86 | |
| Hs.441498 | Signal transducing adaptor molecule 1 ( | 0.014 | 1.29 | |
| Hs.525091 | Testis-specific kinase 2 ( | 0.006 | 1.25 | |
| Hs.355899 | Tumor necrosis factor receptor superfamily, member 12A ( | 0.021 | 0.78 | |
| Hs.47061 | Unc-51-like kinase 1 ( | 0.040 | 1.52 | |
| Hs.646283 | Virus-induced signaling adapter ( | 0.001 | 1.43 | |
| Hs.512079 | WAS protein family, member 2 ( | 0.003 | 2.06 | |
| Cell proliferation, differentiation | Hs.515371 | Calpain, small subunit 1 ( | 0.033 | 0.68 |
| Hs.443625 | Collagen, type III, alpha 1 ( | 0.012 | 1.14 | |
| Hs.150423 | Cyclin-dependent kinase 9 (CDC2-related kinase) ( | 0.039 | 1.59 | |
| Hs.437379 | Development and differentiation enhancing factor-like 1 ( | 0.013 | 1.30 | |
| Hs.130316 | Drebrin 1 ( | 0.045 | 1.53 | |
| Hs.26770 | Fatty acid binding protein 7 ( | 0.011 | 0.64 | |
| Hs.87752 | Moesin ( | 0.031 | 1.35 | |
| Hs.516633 | NCK-associated protein 1 ( | 0.013 | 0.75 | |
| Hs.191346 | Septin 7 ( | 0.024 | 0.75 | |
| Hs.530477 | Signal-induced proliferation-associated gene 1 ( | 0.001 | 1.56 | |
| Hs.527973 | Suppressor of cytokine signaling 3 ( | 0.045 | 1.30 | |
| Hs.386390 | Transcriptional adaptor 3 like ( | 0.015 | 1.58 | |
| Hs.355899 | Tumor necrosis factor receptor superfamily, member 12A ( | 0.021 | 0.78 | |
| Transport | Hs.518060 | ADP-ribosylation-like factor 6 interacting protein 5 ( | 0.009 | 0.69 |
| Hs.511311 | ATPase, Class I, type 8B, member 4 ( | 0.037 | 2.32 | |
| Hs.86905 | ATPase, lysosomal, V1 subunit C, isoform 1 ( | 0.043 | 2.10 | |
| Hs.503721 | Dynein, cytoplasmic, heavy polypeptide 2 ( | 0.021 | 0.53 | |
| Hs.26770 | Fatty acid binding protein 7 ( | 0.011 | 0.64 | |
| Hs.388668 | Kelch-like 2 ( | 0.026 | 0.50 | |
| Hs.645375 | Mitochondrial carrier family protein ( | 0.015 | 0.70 | |
| Hs.477361 | SEC22 vesicle trafficking protein homolog A ( | 0.041 | 0.61 | |
| Hs.458917 | Secretory carrier membrane protein 2 ( | 0.042 | 1.44 | |
| Hs.14846 | Solute carrier family 7 ( | 0.026 | 1.24 | |
| Hs.462379 | Target of myb1-like 2 ( | 0.004 | 1.59 | |
| Hs.352018 | Transporter 1, ATP-binding cassette, sub-family B ( | 0.001 | 3.08 | |
| Metabolism | Hs.591852 | ADAM metallopeptidase domain 9 ( | 0.021 | 1.88 |
| Hs.465720 | Acyl-CoA synthetase bubblegum family member 2 ( | 0.021 | 1.31 | |
| Hs.81934 | Acyl-Coenzyme A dehydrogenase, short/branched chain ( | 0.012 | 1.98 | |
| Hs.88778 | Carbonyl reductase 1 ( | 0.037 | 1.34 | |
| Hs.437379 | Development and differentiation enhancing factor-like 1 ( | 0.013 | 1.30 | |
| Hs.463089 | Dodecenoyl-Coenzyme A delta isomerase ( | 0.038 | 1.37 | |
| Hs.369762 | Enolase superfamily member 1 ( | 0.043 | 0.71 | |
| Hs.79322 | Glutaminyl-tRNA synthetase ( | 0.035 | 1.37 | |
| Hs.647690 | Glyceraldehyde 3-phosphate dehydrogenase ( | 0.003 | 1.27 | |
| Hs.524418 | Glycerol-3-phosphate dehydrogenase 1 ( | 0.010 | 0.44 | |
| Hs.180878 | Lipoprotein lipase ( | 0.002 | 0.65 | |
| Hs.162757 | Low density lipoprotein-related protein 1 ( | 0.036 | 0.68 | |
| Hs.514713 | Metallophosphoesterase 1 ( | 0.047 | 1.39 | |
| Hs.94949 | Methylmalonyl CoA epimerase ( | 0.039 | 0.54 | |
| Hs.518424 | NADH dehydrogenase 1 beta subcomplex, 5 ( | 0.008 | 0.49 | |
| Hs.12851 | Phosphatidylserine synthase 2 ( | 0.036 | 1.34 | |
| Hs.368157 | Phosphorylase, glycogen ( | 0.037 | 1.34 | |
| Hs.98381 | Protease, serine, 35 ( | 0.010 | 0.67 | |
| Hs.471441 | Proteasome subunit, beta type, 2 ( | 0.043 | 0.71 | |
| Hs.548558 | Similar to cathepsin D ( | 0.034 | 1.55 | |
| Hs.156668 | Ubiquinone oxidoreductase complex B15 subunit ( | 0.002 | 2.21 | |
| Hs.272011 | UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 1 ( | 0.037 | 1.26 | |
| Electron transport | Hs.81934 | Acyl-Coenzyme A dehydrogenase, short/branched chain ( | 0.012 | 1.98 |
| Hs.201667 | Aldo-keto reductase family 1, member D1 ( | 0.015 | 2.51 | |
| Hs.433901 | Cytochrome c oxidase subunit 8A (ubiquitous) ( | 0.021 | 1.42 | |
| Hs.511367 | Cytochrome P450, family 19, subfamily A, polypeptide 1 ( | 0.029 | 1.79 | |
| Hs.642706 | Flavin containing monooxygenase 5 ( | 0.013 | 1.72 | |
| Hs.211046 | Hypothetical protein LOC126248 ( | 0.002 | 2.24 | |
| Hs.518424 | NADH dehydrogenase 1 beta subcomplex, 5 ( | 0.008 | 0.49 | |
| Hs.125221 | Thioredoxin domain containing 1 ( | 0.003 | 1.48 | |
| Immune response | Hs.529019 | Bactericidal/permeability-increasing protein ( | 0.002 | 2.02 |
| Hs.534255 | Beta-2-microglobulin ( | 0.021 | 1.92 | |
| Hs.504641 | CD163 antigen ( | 0.023 | 1.29 | |
| Hs.278694 | CD209 antigen ( | 0.003 | 1.47 | |
| Hs.372679 | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) ( | 0.050 | 1.66 | |
| Hs.3268 | Heat shock 70 kDa protein (HSP70B, | 0.001 | 1.28 | |
| Hs.497723 | Hypothetical protein MGC27165 ( | 0.011 | 1.42 | |
| Hs.449585 | Immunoglobulin lambda locus ( | 0.001 | 3.03 | |
| Hs.389724 | Interferon-induced protein 44-like ( | 0.001 | 2.53 | |
| Hs.77961 | Major histocompatibility complex, class I, B ( | 0.001 | 2.44 | |
| Hs.548432 | Similar to CD63 antigen ( | 0.016 | 0.49 | |
| Hs.370937 | TAP binding protein (tapasin, | 0.031 | 1.91 | |
| Hs.352018 | Transporter 1, ATP-binding cassette, sub-family B ( | 0.001 | 3.08 | |
1Fold change is the ratio of CONV versus GF.
Figure 1Directed acyclic graph (DAG) of significantly enriched GO categories generated using GOTree Machine (GOTM) software. Categories with significantly enriched gene numbers as determined by hypergeometric test are indicated in red while those in black are non-enriched. GOTM analysis demonstrated that more specific biological processes such as immune response, regulation of hydrolase activity, peptide transport and JAK-STAT cascade were significantly modulated by the microbiota. Number of observed genes in a particular biological process is indicated by "n".
Figure 2Functional relationships among the differentially expressed genes were generated using Ingenuity Pathways Analysis. Direct interactions are shown by solid lines and indirect interactions are depicted by broken lines. Red and green colors indicate up- and downregulation in CONV versus GF epithelia, respectively, whereas no color indicates that nodes were not differentially expressed on the array. The network is showing direct literature-supported relationships and confirms the interferon-mediated activation of transcription factors STAT1 and STAT2, which are involved in the expression of IFN-inducible target genes such as class I MHC (HLA-B in figure; pan SLA I on array and by qRT-PCR), B2M, TAP1, TAPBP, and SOCS3 in CONV compared with GF piglets.
Comparison of expression patterns (fold change) observed with microarray versus qRT-PCR analysis
| Gene symbol | Gene expression with qRT-PCR1 | Microarray analysis | ||||
| GF | CONV | Ratio | Ratio | FDR adjusted | ||
| 1.00 ± 0.21 | 1.81 ± 0.21 | 1.81 | 0.05 | 1.79 | ||
| 1.00 ± 0.08 | 1.69 ± 0.12 | 1.69 | 0.01 | 0.97 | ||
| 1.00 ± 0.55 | 3.09 ± 0.63 | 3.09 | 0.05 | 0.83 | ||
| 0.73 ± 0.22 | 1.56 ± 0.22 | 2.14 | 0.04 | 1.53 | 0.013 | |
| 1.00 ± 0.32 | 2.62 ± 0.46 | 2.62 | 0.05 | 1.52 | 0.030 | |
| 0.52 ± 0.54 | 1.42 ± 0.63 | 2.73 | 0.07 | 2.31 | 0.003 | |
| 0.98 ± 0.28 | 2.09 ± 0.28 | 2.13 | 0.03 | 1.86 | 0.001 | |
| 1.00 ± 0.18 | 3.05 ± 0.20 | 3.05 | 0.03 | 1.01 | ||
| pan SLA I | 1.42 ± 0.73 | 4.53 ± 0.85 | 3.19 | 0.04 | 2.44 | 0.001 |
| 1.13 ± 0.36 | 5.17 ± 0.42 | 4.58 | 0.01 | 3.97 | 0.009 | |
1Values are means ± SE, n = 3/4 per treatment group. RNA was isolated from ileal sample of GF versus CONV piglets using Trizol reagent. Quantitative RT-PCR analysis of gene expression was determined by QuantiTect SYBR Green RT-PCR Master Mix in a 384-well plate using an ABI Prism 7900 HT SS instrument.